These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 26702075

  • 1. Forced expression of muscle specific kinase slows postsynaptic acetylcholine receptor loss in a mouse model of MuSK myasthenia gravis.
    Ghazanfari N, Linsao EL, Trajanovska S, Morsch M, Gregorevic P, Liang SX, Reddel SW, Phillips WD.
    Physiol Rep; 2015 Dec; 3(12):. PubMed ID: 26702075
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN, Reddel SW, Gervásio OL, Phillips WD.
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of the ß2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis.
    Ghazanfari N, Morsch M, Tse N, Reddel SW, Phillips WD.
    PLoS One; 2014 Jun; 9(2):e87840. PubMed ID: 24505322
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Specific binding of collagen Q to the neuromuscular junction is exploited to cure congenital myasthenia and to explore bases of myasthenia gravis.
    Ohno K, Ito M, Kawakami Y, Krejci E, Engel AG.
    Chem Biol Interact; 2013 Mar 25; 203(1):335-40. PubMed ID: 22981737
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM, Van Den Broeck J, Vrolix K, Janssen SP, Lemmens MA, Van Der Esch E, Duimel H, Frederik P, Molenaar PC, Martínez-Martínez P, De Baets MH, Losen M.
    Autoimmunity; 2010 Aug 25; 43(5-6):353-70. PubMed ID: 20380584
    [Abstract] [Full Text] [Related]

  • 12. Muscle specific kinase protects dystrophic mdx mouse muscles from eccentric contraction-induced loss of force-producing capacity.
    Trajanovska S, Ban J, Huang J, Gregorevic P, Morsch M, Allen DG, Phillips WD.
    J Physiol; 2019 Sep 25; 597(18):4831-4850. PubMed ID: 31340406
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.
    Losen M, Stassen MH, Martínez-Martínez P, Machiels BM, Duimel H, Frederik P, Veldman H, Wokke JH, Spaans F, Vincent A, De Baets MH.
    Brain; 2005 Oct 25; 128(Pt 10):2327-37. PubMed ID: 16150851
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity.
    Punga AR, Maj M, Lin S, Meinen S, Rüegg MA.
    Eur J Neurosci; 2011 Mar 25; 33(5):890-8. PubMed ID: 21255125
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.